Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
As world leaders enter climate talks, people in poverty have the most at stake - 27 Powerful Techniques to Boost Efficiency with Your Cell Phone: A Thorough Aide
- 3Track down the Ideal Weight reduction Methodology for Your Way of life
- 45 Bike Brands for Ordinary Use
- 5Protest inspired by 'Gen Z' movement draws few young people in Mexico and many government critics
- Israeli police block Latin Patriarch from Palm Sunday mass in Jerusalem
- 'Euphoria' releases Season 3 trailer, premiere date: Watch Rue and Laurie finally face off
- ‘The White Lotus’ sparked online interest in risky anxiety pills, study says
- FDA official discusses potential link between COVID-19 vaccines and pediatric deaths
- Audits of 6 Specialty Mixed drinks
- Tatiana Schlossberg, a granddaughter of JFK, is dead at 35 after cancer diagnosis
- Germany ready to assist Syria's reconstruction, says foreign minister
- Iran, Hezbollah fire rockets at Israel during Passover celebrations
- Northern lights chances rise for Christmas as space weather remains unsettled
